Type 2 Diabetes in Youth: Epidemiology and Pathophysiology
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
The prevalence of type 2 diabetes is significantly increased in the pediatric population, which is affected by obesity worldwide. The progression from normal glucose tolerance (NGT) to type 2 diabetes involves intermediate stages of impaired fasting glucose (IFG) and impaired glucose tolerance (IGT), also known as prediabetes. The pathophysiology underlying the development of these glucose metabolic alterations is multifactorial; however an alteration in the balance between insulin sensitivity and insulin secretion represents the most important player in the development of type 2 diabetes. Obese children and adolescents affected by IGT and type 2 diabetes are characterized by severe insulin resistance, which is associated with an increased lipid accumulation in visceral compartments, liver and muscle tissues and by reduced sensitivity of I²-cell of first and second-phase insulin secretion. The progression in obese children of insulin resistance to type 2 diabetes has been shown to be faster than in adults; in addition, type 2 diabetes is already associated with several metabolic and cardiovascular complications in this age group. In the present review, we summarize the most recent findings concerning the prevalence of type 2 diabetes in youth and in particular we explore the pathophysiology of type 2 diabetes and the natural history of this pathology in obese children and adolescents. Concurrent with the worldwide epidemic increase of childhood obesity, type 2 diabetes and the two prediabetic conditions, IFG and IGT, are becoming increasingly more common in obese children and adolescents (1,2). Until 10 years ago, type 2 diabetes accounted for less than 3% of all cases of new-onset diabetes in adolescents. At present 45% of cases are attributed to it (3,4). Type 2 diabetes occurs in youth more often during the second decade of life, coinciding with the physiological occurrence of pubertal insulin resistance (1). In addition, …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 A: Baseline values of the dynamic β-cell responsivity (Φd) in subjects who maintained NGT (nonprogressors [NP]) and in subjects who developed IGT (progressors [P]) (P = 0.04). B: Changes of the DI values according to changes in glucose tolerance over the course of approximately 30 months. Subjects who developed IGT (progressors) experienced a progressive decline of overall β-cell function, as assessed by the DI. OGTT, oral glucose tolerance test.*P = 0.04.](https://figures.cochat.ai/paper-figures/cb715871c23742ee9f771e1551b9fb72/type-2-diabetes-in-youth-epidemiology-and-pathophysiology-figure-2.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Staggeringly, 80% of all new diabetes cases in Japan in children and adolescents were reported as T2D and other countries have also reported an increase in youth T2D.60”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [60]
In the citing paper
“However, many studies from Europe have reported that youth T2D is much rarer, accounting for only 1–2% of all diabetes mellitus cases.55,60”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [60]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanisms linking obesity to insulin resistance and type 2 diabetes
Kahn, S. E., Hull, R. L., & Utzschneider, K. M. (2006) · Nature · doi:10.1038/nature05482 · Cited by 5,448 · cited 1×
“The ability of the b-cell to secrete sufficient insulin to adequately respond to the peripheral insulin resistance state depends on multiple factors, including b-cell mass (14) and secretory capacity (14), which are influenced by genetic (15) and environmental factors (15).”
BackgroundDeFronzo, R. A. (2009) · Diabetes · doi:10.2337/db09-9028 · Cited by 3,016
Cellular mechanisms of insulin resistance
Shulman, G. I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10583 · Cited by 2,714
Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications
Fabbrini, E., Sullivan, S., & Klein, S. (2010) · Hepatology · doi:10.1002/hep.23280 · Cited by 2,100 · cited 1×
“Although it remains unclear whether hepatic steatosis is a consequence or a cause of derangements in insulin sensitivity, the presence of steatosis is an important marker of multiorgan insulin resistance (29); moreover, insulin resistance is directly related to percent liver fat (29).”
BackgroundPrevalence of impaired glucose tolerance among children and adolescents with marked obesity
Sinha, R., Fisch, G., Teague, B., Tamborlane, W. V., Banyas, B., Allen, K., Savoye, M., Rieger, V., Taksali, S., Barbetta, G., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012578 · Cited by 1,709 · cited 1×
“In particular, 25% of children and 21% adolescents with severe degree of obesity, irrespective of ethnicity, were found to have IGT (10).”
BackgroundSelf-citationImpaired Fasting Glucose and Impaired Glucose Tolerance
Nathan, D. M., Davidson, M. B., DeFronzo, R. A., Heine, R. J., Henry, R. R., Pratley, R., & Zinman, B. (2007) · Diabetes Care · doi:10.2337/dc07-9920 · Cited by 1,396
Incidence of diabetes in youth in the United States
SEARCH for Diabetes in Youth Study Group*, T. W. G. F. T. (2007) · JAMA · doi:10.1001/jama.297.24.2716 · Cited by 991
Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity
Fabbrini, E., Magkos, F., Mohammed, B. S., Pietka, T., Abumrad, N. A., Patterson, B. W., Okunade, A., & Klein, S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904944106 · Cited by 972 · cited 1×
“Despite the demonstrated relationship between IMCL, visceral fat, and metabolic dysfunction, the ectopic fat deposition in the liver is emerging as the most important marker of insulin resistance and glucose dysregulation in adults (27) as well as in obese pediatric population (28).”
BackgroundClinical risk factors, DNA variants, and the development of type 2 diabetes
Lyssenko, V., Jonsson, A., Almgren, P., Pulizzi, N., Isomaa, B., Tuomi, T., Berglund, G., Altshuler, D., Nilsson, P., & Groop, L. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801869 · Cited by 938
Type 2 Diabetes in Children and Adolescents
(2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.02.035 · Cited by 926
The global spread of type 2 diabetes mellitus in children and adolescents
Pinhas-Hamiel, O., & Zeitler, P. (2005) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2004.12.042 · Cited by 652 · cited 3×
“EPIDEMIOLOGY—In the last two decades, type 2 diabetes, once thought to be a metabolic disorder exclusively of adulthood, has become increasingly more frequent in obese adolescents (3).”
BackgroundUtzschneider, K. M., Prigeon, R. L., Faulenbach, M. V., Tong, J., Carr, D. B., Boyko, E. J., Leonetti, D. L., McNeely, M. J., Fujimoto, W. Y., & Kahn, S. E. (2009) · Diabetes Care · doi:10.2337/dc08-1478 · Cited by 572 · cited 1×
“Studies conducted in adult populations (19) have demonstrated that the DI is not only a measure for identifying subjects with poor b-cell function but also a strong predictor for the development of type 2 diabetes.”
BackgroundWeiss, R., Dufour, S., Taksali, S. E., Tamborlane, W. V., Petersen, K. F., Bonadonna, R. C., Boselli, L., Barbetta, G., Allen, K., Rife, F., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14364-4 · Cited by 499 · cited 6×
“Just as in adults, the pattern of development is oftenprecededby an intermediate state of impaired glucose tolerance (IGT) (6).”
BackgroundInfluentialSelf-citationAcute and chronic complications of type 2 diabetes mellitus in children and adolescents
Pinhas-Hamiel, O., & Zeitler, P. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60821-6 · Cited by 385 · cited 4×
“Microvascular complications can be present at time of diagnosis with a progression rate that might be higher than in young people with type 1 diabetes (4).”
BackgroundInfluentialPredictors of Changes in Glucose Tolerance Status in Obese Youth
Weiss, R., Taksali, S. E., Tamborlane, W. V., Burgert, T. S., Savoye, M., & Caprio, S. (2005) · Diabetes Care · doi:10.2337/diacare.28.4.902 · Cited by 378
Self-citationBurgert, T. S., Taksali, S. E., Dziura, J., Goodman, T. R., Yeckel, C. W., Papademetris, X., Constable, R. T., Weiss, R., Tamborlane, W. V., Savoye, M., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1010 · Cited by 369 · cited 1×
“Previously, we reported that rising alanine transaminase levels in obese children and adolescents were associated with deterioration in insulin sensitivity and glucose tolerance (30).”
BackgroundSelf-citationHigh Visceral and Low Abdominal Subcutaneous Fat Stores in the Obese Adolescent
Taksali, S. E., Caprio, S., Dziura, J., Dufour, S., Calí, A. M. G., Goodman, T. R., Papademetris, X., Burgert, T. S., Pierpont, B. M., Savoye, M., et al. (2008) · Diabetes · doi:10.2337/db07-0932 · Cited by 353 · cited 1×
“Indeed, by stratifying a multiethnic cohort of obese adolescents into tertiles based on the proportion of visceral fat in the abdomen (visceral/subcutaneous fat ratio), we observed a significant increase in 2-h glucose and insulin resistance (homeostasis model assessment) and decrease in insulin sensitivity (Matsuda i…”
BackgroundSelf-citationPetersen, K. F., Dufour, S., & Shulman, G. I. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020233 · Cited by 308
Rising Incidence of Type 2 Diabetes in Children in the U.K.
Haines, L., Wan, K. C., Lynn, R., Barrett, T. G., & Shield, J. P. H. (2007) · Diabetes Care · doi:10.2337/dc06-1813 · Cited by 258
Goran, M. I., Bergman, R. N., Avila, Q., Watkins, M., Ball, G. D. C., Shaibi, G. Q., Weigensberg, M. J., & Cruz, M. L. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031402 · Cited by 236
Weiss, R., Dufour, S., Groszmann, A., Petersen, K., Dziura, J., Taksali, S. E., Shulman, G., & Caprio, S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021711 · Cited by 193 · cited 2×
“In a previous studies by our group (6,24) we observed an association between IMCL and insulin resistance in children with prediabetes (6) and a strong inverse correlation between IMCL and adiponectin (24) in obese children and adolescents.”
BackgroundSelf-citationTwo-Hour Seven-Sample Oral Glucose Tolerance Test and Meal Protocol
Dalla Man, C., Campioni, M., Polonsky, K. S., Basu, R., Rizza, R. A., Toffolo, G., & Cobelli, C. (2005) · Diabetes · doi:10.2337/diabetes.54.11.3265 · Cited by 179 · cited 1×
“2A), as indicated by the glucose b-cell responsitivity (Fd), measured by the oral minimal model (21).”
Methodβ-Cell Function Across the Spectrum of Glucose Tolerance in Obese Youth
Weiss, R., Caprio, S., Trombetta, M., Taksali, S. E., Tamborlane, W. V., & Bonadonna, R. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1735 · Cited by 164 · cited 1×
“Thus at diagnosis, just as in the adults (5), ;80% of their b-cell function is reduced or lost (16).”
BackgroundSelf-citationGlucose dysregulation and hepatic steatosis in obese adolescents: Is there a link?†‡
Cali, A. M. G., De Oliveira, A. M., Kim, H., Chen, S., Reyes‐Mugica, M., Escalera, S., Dziura, J., Taksali, S. E., Kursawe, R., Shaw, M., et al. (2009) · Hepatology · doi:10.1002/hep.22858 · Cited by 163 · cited 2×
“In order to understand the potential role of fatty liver in the onset of type 2 diabetes in obese youth, we have recently assessed whether the severity of hepatic steatosis affects the presence of glucose metabolism dysregulation in a multiethnic cohort of obese adolescents (28).”
BackgroundSelf-citationPresence of Diabetes Risk Factors in a Large U.S. Eighth-Grade Cohort
The STOPP-T2D Prevention Study Group (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1037 · Cited by 157
Type 2 diabetes in children and adolescents
Rosenbloom, A. L., Silverstein, J. H., Amemiya, S., Zeitler, P., & Klingensmith, G. J. (2009) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2009.00584.x · Cited by 148
Type 2 Diabetes in Children is Frequently Associated with Elevated Alanine Aminotransferase
Nadeau, K. J., Klingensmith, G., & Zeitler, P. (2005) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/01.mpg.0000164698.03164.e5 · Cited by 145 · cited 1×
“Furthermore, abnormal alanine transaminase levels were found in children with type 2 diabetes (31).”
BackgroundCruz, M. L., Bergman, R. N., & Goran, M. I. (2002) · Diabetes Care · doi:10.2337/diacare.25.9.1631 · Cited by 139 · cited 1×
“(26) showed a direct impact of visceral fat accumulation on insulin sensitivity and secretion, independent of total body adiposity, in obese children with a family history of type 2 diabetes.”
BackgroundCali, A. M. G., Man, C. D., Cobelli, C., Dziura, J., Seyal, A., Shaw, M., Allen, K., Chen, S., & Caprio, S. (2009) · Diabetes Care · doi:10.2337/dc08-1274 · Cited by 125
Self-citationMetabolic Abnormalities Underlying the Different Prediabetic Phenotypes in Obese Adolescents
Cali', A. M. G., Bonadonna, R. C., Trombetta, M., Weiss, R., & Caprio, S. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1722 · Cited by 124 · cited 2×
“Furthermore, in order to assess whether the defects in b-cell function characterize all of the various prediabetic conditions seen in obese adolescents, in a cross-sectional analyses (17) we compared the b-cell function and tissue insulin sensitivity among subjects with NGT, IFG, IGT, or combined IFG/IGT.”
BackgroundResultSelf-citationDIABETES IN CHILDREN AND ADOLESCENTS
KAUFMAN, F. R. (1998) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70021-3 · Cited by 108
Progressive beta cell failure in type 2 diabetes mellitus of youth
Gungor, N., & Arslanian, S. A. (2004) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2003.12.045 · Cited by 99 · cited 1×
“In fact, an interesting report by Gungor and Arslanian (33) suggested that despite a relatively robust initial insulin secretion, the deterioration in b-cell function in youth with type 2 diabetes is more accelerated (;15% per year) than that observed in adults.”
BackgroundBrufani, C., Ciampalini, P., Grossi, A., Fiori, R., Fintini, D., Tozzi, A., Cappa, M., & Barbetti, F. (2010) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2009.00527.x · Cited by 68 · cited 3×
“5% and 5%, respectively) (12), a recent study conducted in Italy (13) on a large sample of overweight/obese children and adolescents reported a prevalence of glucose metabolism alterations of 12.”
BackgroundInfluentialThe hyperbolic equilibrium between insulin sensitivity and secretion
Pacini, G. (2006) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2005.10.014 · Cited by 47 · cited 1×
“This equilibrium is quantitatively described by the “disposition index” (DI), which is the product of insulin sensitivity and b-cell function and therefore can be considered an index of b-cell function weighted by insulin sensitivity (18).”
BackgroundImpaired Glucose Tolerance in Obese Children and Adolescents
Uwaifo, G. I., Elberg, J., & Yanovski, J. A. (2002) · New England Journal of Medicine · doi:10.1056/nejm200207253470414 · Cited by 36 · cited 1×
“5% and 5%, respectively) (12), a recent study conducted in Italy (13) on a large sample of overweight/obese children and adolescents reported a prevalence of glucose metabolism alterations of 12.”
BackgroundZavaroni, I., Ardigò, D., Zuccarelli, A., Pacetti, E., Piatti, P. M., Monti, L. D., Valtueña, S., Massironi, P., Rossi, P. C., & Reaven, G. M. (2005) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2004.11.003 · Cited by 25
Cited by
Type 2 diabetes in adolescents and young adults
Lascar, N., Brown, J., Pattison, H., Barnett, A. H., Bailey, C. J., & Bellary, S. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30186-9 · Cited by 824
Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease
Thomas, M. C., Cooper, M. E., & Zimmet, P. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2015.173 · Cited by 742
The Role of Obesity in Type 2 Diabetes Mellitus—An Overview
Chandrasekaran, P., & Weiskirchen, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031882 · Cited by 465
“Recently, different drugs have been approved to improve type 2 DM and promote weight loss such as GLP-1 receptor agonists and SGLT2 inhibitors [4].”
BackgroundReed, J., Bain, S., & Kanamarlapudi, V. (2021) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s319895 · Cited by 441
Obesity and diabetes—Not only a simple link between two epidemics
Chobot, A., Górowska‐Kowolik, K., Sokołowska, M., & Jarosz‐Chobot, P. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3042 · Cited by 281
Metadata
- Authors
- D’Adamo, E., & Caprio, S.
- Affiliations
- Yale University (US)
- Corresponding author
- Caprio, Sonia
- ORCID
- Caprio, Sonia
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2011-04-22
- Volume
- 34
- Issue
- Supplement_2
- Pages
- S161-S165
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3632155
- OpenAlex
- W2114855885
- Cited by
- 315
- References
- 36
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 11 · 2023: 13 · 2022: 18 · 2021: 30 · 2020: 29 · 2019: 24 · 2018: 33 · 2017: 33 · 2016: 39 · 2015: 22 · 2014: 26 · 2013: 11 · 2012: 12
- FWCI
- 3.01
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- F. Hoffmann-La Roche
- Georgia Clinical and Translational Science Alliance
- Novo Nordisk
- National Institutes of Health (and K24)
- National Center for Research Resources (UL1 RR0249139)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01-HD- 28016, R01HD028016, R01-HD40787, K24HD001464, R01HD040787, K24-HD01464)
- Daiichi Sankyo Europe
- Cilag
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 2 diabetes, youth, childhood obesity, adolescents, prediabetes, impaired fasting glucose, impaired glucose tolerance, insulin resistance, insulin secretion, beta-cell function, natural history (disease), diabetes prevalence, cardiovascular complications
- MeSH terms
- Adolescent, Diabetes Mellitus, Type 2, Female, Humans, Male
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.